Efficacy and Safety of Long-Term Tildrakizumab for Plaque Psoriasis: 4-Year Results from Resurface 1 and Resurface 2. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 5, p. s39, 2020. DOI: 10.25251/skin.4.supp.39. Disponível em: https://skin.dermsquared.com/skin/article/view/988. Acesso em: 19 apr. 2026.